title: AHA Scientific Statement: Recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association.
authors.forename: C S
authors.initials: CS
authors.lastname: Ogilvy
authors.forename: P E
authors.initials: PE
authors.lastname: Stieg
authors.forename: I
authors.initials: I
authors.lastname: Awad
authors.forename: R D
authors.initials: RD
authors.lastname: Brown
authors.forename: D
authors.initials: D
authors.lastname: Kondziolka
authors.forename: R
authors.initials: R
authors.lastname: Rosenwasser
authors.forename: W L
authors.initials: WL
authors.lastname: Young
authors.forename: G
authors.initials: G
authors.lastname: Hademenos
mesh_terms: D000572:American Heart Association; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002548:Cerebral Revascularization / Q000592:standards*; D015331:Cohort Studies; D003131:Combined Modality Therapy; D004621:Embolization, Therapeutic / Q000592:standards*; D005260:Female; D006261:Headache / Q000209:etiology; D006801:Humans; D015994:Incidence; D002538:Intracranial Arteriovenous Malformations / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D020300:Intracranial Hemorrhages / Q000209:etiology / Q000517:prevention & control; D008297:Male; D008910:Minnesota; D009426:Netherlands; D015995:Prevalence; D016634:Radiosurgery / Q000592:standards*; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D018570:Risk Assessment; D012640:Seizures / Q000209:etiology; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents